macular degeneration

April 19, 2024

A ‘Site’ for Sore Eyes

Four years ago, Roger Lasater went outside to look at the stars and the moon and couldn’t see them. He was was in the beginning stages of age-related macular degeneration, one of the many eye diseases studied by physician-scientists at the Vanderbilt Eye Institute.

By Nancy Humphrey
August 15, 2022

Mitochondria and retinal degeneration

Vanderbilt researchers have developed a new cellular model for exploring mitochondrial dysfunction in age-related macular degeneration, the leading cause of blindness in people over 65.

By Leigh MacMillan
July 1, 2019

Research to Prevent Blindness awards grants to Department of Ophthalmology

Vanderbilt Eye Institute receives grants to Research to study causes, treatment and prevention of blinding diseases.

By Jessica Pasley
February 16, 2017

Grant strengthens Brantley’s vision research efforts

Milam Brantley Jr., M.D., Ph.D., associate professor of Ophthalmology and Visual Sciences and Molecular Physiology and Biophysics, recently received a $500,000 grant from the Edward N. and Della L. Thome Memorial Foundation Awards Program in Macular Degeneration Research to further his work on age-related macular degeneration (AMD).

By Jessica Pasley
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.

By Bill Snyder
September 27, 2013

Metabolic profiling of vision loss

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.

By Leigh MacMillan